4.5 Article

Protecting-Group-Free Total Synthesis of Anticancer (±)-Melotenine A

Journal

SYNTHESIS-STUTTGART
Volume 54, Issue 7, Pages 1850-1856

Publisher

GEORG THIEME VERLAG KG
DOI: 10.1055/a-1633-8333

Keywords

natural product synthesis; melotenine A; anticancer agent; Diels-Alder reaction; ring-closing metathesis

Funding

  1. Thailand Research Fund [DBG5480018]
  2. Royal Golden Jubilee Advanced Program under the Thailand Research Fund [RAP61K0005]
  3. Kasetsart University Research and Development Institute (KURDI)
  4. Center of Excellence for Innovation in Chemistry (PERCH-CIC)
  5. Ministry of Higher Education, Science, Research and Innovation, Thailand
  6. Department of Chemistry, Faculty of Science, Kasetsart University

Ask authors/readers for more resources

Melotenine A, derived from Melodinus tenuicaudatus, shows significant anticancer activity against several human cancer cell lines. The synthesis of (+/-)-melotenine A was achieved in 11 steps with an overall yield of 6.7%, using key steps including a Diels-Alder reaction and ring-closing metathesis.
Melotenine A, isolated from Melodinus tenuicaudatus , possesses significant anticancer activity against several human cancer cell lines. The synthesis of (+/-)-melotenine A was achieved without the use of any protecting groups in 11 steps with an overall yield of 6.7%. The key steps of our strategy were a Diels-Alder reaction to construct the tetracyclic framework and ring-closing metathesis to form the seven-membered ring of (+/-)-melotenine A.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available